Lamin Labs
Git for biology R&D data
Munich, Bavaria, Germany
Lamin Labs offers an open data platform for biology, providing a lineage-native lakehouse framework. This platform enables querying, tracing, and validating biological datasets and models at scale, allowing free exploration of public datasets without an account.
Problem Statement
Difficulty in efficiently querying, tracing, and validating complex biological datasets and models at scale, and barriers to freely exploring public biological datasets.
Core Technology
lineage-native lakehouse framework for querying, tracing, and validating biological datasets and models
Key Differentiators
Free open-source package; Open data platform allows free exploration of public datasets without account requirement
Clinical Focus
Genomics; Transcriptomics; Proteomics; Metabolomics; Cell Biology; Bioinformatics
Company Info
- Business Model
- B2B SaaS
- Founded
- 2022
- Total Funding
- 500,000
- Website
- www.lamin.ai
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
Used by enterprise biotech (Pfizer) and academic institutions (Broad Institute, Stanford, Charité, Helmholtz Munich). Open-source platform adopted by thousands of scientists
MedStartr Index Score
?What do you think of Lamin Labs?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.